We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.

About Mi Vademecum

My Vademecum Argentina, see thousands of drugs and prospects for free!

My Vademécum Argentina is a free mobile application that allows you to access over 5000 prospects legal drugs circulation in Argentina.

In this first version, the application offers the following features:

- Displaying more than 5000 drugs.

- Quick Search drug name.

- Viewing prospect of medicines.

- Search classification and associated therapeutic drugs.

- Finder active ingredient and associated medications.

- search laboratories and associated medications.

- History newer drugs.

See agile and easily interrelated indexes:

-products: medications, absorbents, bio-security, dermo cosmetics, infant formula, health, homeopathic, medical and hospital, natural ingredients, food supplements and vitamins.

-Principles active: the drugs alone and in combination.

-Laboratories: distributors and / or representatives contact information.

MI VADEMECUM does not seek to promote autoprescripción or replace the work of the doctor. Medications should always be used under prescription and monitoring health care professional.

What's New in the Latest Version 1.0.6

Last updated on Apr 4, 2023

- Mejoras de diseño
- Mejoras de rendimiento
- Corrección de errores

Translation Loading...

Additional APP Information

Latest Version

Request Mi Vademecum Update 1.0.6

Uploaded by

Tuấn JP

Requires Android

Android 4.4+

Available on

Get Mi Vademecum on Google Play

Show More

Mi Vademecum Screenshots

Languages
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.